Skip to main content
Journal of Psychiatry & Neuroscience: JPN logoLink to Journal of Psychiatry & Neuroscience: JPN
. 2008 Jan;33(1):47–53.

Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults

Hsien-Yuan Lane 1, Yi-Ching Liu 1, Chieh-Liang Huang 1, Ching-Liang Hsieh 1, Yi-Lin Chang 1, Lauren Chang 1, Yue-Cune Chang 1, Wen-Ho Chang 1
PMCID: PMC2186374  PMID: 18197272

Abstract

Objective

The Val158Met polymorphism of the catechol-O-methyltransferase gene has been demonstrated to be associated with prefrontal executive function explaining 4% of variance in perseverative errors on the Wisconsin Card Sorting Test (WCST). Studies suggest that dopamine D1 and D3 and serotonin 5-HT2A and 5-HT6 receptors may also be involved in prefrontal cognitive function and that genetic polymorphisms (D1 A-48G, D3 Ser9Gly, 5-HT2A T102C, and 5-HT6 T267C) of these receptors may be associated with brain glucose metabolism or neurophysiological function. The current study's objective was to investigate whether executive function varies with these genetic variations.

Methods

A sample of 216 healthy Han Chinese adults were measured with the WCST and genotyped for the 4 genetic polymorphisms.

Results

Kruskal–Wallis tests showed a significant difference in WCST perseverative errors among the genotypes D3 Ser9Gly (p = 0.009), 5-HT2A T102C (p = 0.038) and 5-HT6 T267C (p = 0.010), but not in the genotype D1 A-48G. Multiple regression analysis for the WCST natural logarithm values (i.e., for fulfilling the normal distribution requirement) showed that subjects' perseverative errors were significantly influenced by D1 A-48G, D3 Ser9Gly, 5-HT2A T102C and 5-HT6 T267C polymorphisms after adjustment of other variables.

Conclusion

The preliminary data suggest that D1, D3, 5-HT2A and 5-HT6 genetic mutations may influence prefrontal executive cognition in healthy adults. Further studies in larger samples with other ethnicities or in mentally ill patients are warranted.

Medical subject headings: receptor, dopamine, D1; receptor, dopamine, D3; receptor, serotonin, 5-HT2A; receptor, serotonin, 5-HT6; prefrontal; cognition

Introduction

Genetic factors can influence frontal structures and related test performances.1,2 Converging evidence suggests that dopaminergic neurotransmission affects prefrontal functioning3 and other cognitive domains.4–6 Catechol-O-methyltransferase (COMT) is the key enzyme regulating dopamine metabolism within the prefrontal cortex.7 It has been demonstrated that Val158Met, a functional polymorphism in the COMT gene, is associated with prefrontal cognitive function, explaining 4% of variance in perseverative errors on the Wisconsin Card Sorting Test (WCST) in schizophrenia patients, unaffected siblings and healthy individuals.8 The WCST, a widely used measure of prefrontal cognitive functions (including executive function, abstraction and working memory), is sensitive to a person's ability to generate hypotheses, establish response sets and fluently shift sets.9,10 A recent meta-analysis11 suggests that there is a small but significant relation between Val158Met genotype and WCST performance in healthy people but not in those with schizophrenia.

Because the COMT Val158Met polymorphism accounts for a small portion of the variability in prefrontal cognition, it is warranted to explore whether other genetic mutations have potential effects. Of dopamine receptors, D1 and D3 may deserve foremost attention. D1 receptors play a critical role in the activation of prefrontal cognition such as working memory.12 In the the rat medial prefrontal cortex, the D1 receptor is also essential for selecting response in skilled nonautomatic tasks.3 In addition, D1 activation modulates rodents' social cognition,13 which depends substantially on prefrontal function.14 Among genetic variants of D1 receptors, the A-48G polymorphism is associated with glucose metabolic rates in human brain regions, including the prefrontal cortex.15

The D3 receptor, although structurally highly homologous to other D2-like dopamine receptors, differs from them in regulating neuropsychological performance.16,17 In healthy people, D2 receptor occupancy is correlated with motor tasks rather than with domains involving prefrontal cognitive functions.6 D2 may also regulate spatial working memory, but the latter is principally attributed to D1 receptor–mediated mechanisms.16 In comparison, D3 receptors mediate dopamine-related prefrontal neurocognition18 independently with D1 activation.16 Of D3 genetic variances, a functional polymorphism, Ser9Gly, determines eye movement disturbances,19 which are related to deficient working memory20,21 and attention.22

By interacting with the dopaminergic system, serotonergic transmission also plays a significant role in prefrontal cognitive function.23 Its action is mediated via specific receptors, possibly serotonin 5-HT2A and 5-HT6, located in crucial brain structures, primarily the nucleus basalis magnocellularis–frontal cortex. In rats, 5-HT2A receptors regulate prefrontal cortex–related execution of primed responses.3 In healthy volunteers, 5-HT2A agonists impair the continuous performance task,24 which is mainly determined by prefrontal function.25 Among 5-HT2A receptor polymorphisms, T102C has received considerable attention. For instance, this genetic variance affects treatment response to antipsychotics.26 It also affects N100 amplitude of event-related potentials,27 which are mediated by both frontal and temporal networks.28 Although the T102C substitution does not alter amino acid sequence, recent evidence29 indicates that total levels of 5-HT2A receptor messenger ribonucleic acid (mRNA) and protein in healthy people with the C/C genotype are lower than those in healthy people with the T/T genotype.

The 5-HT6 receptor is responsible for endogenous 5-HT–mediated facilitation of dopamine release in the rat prefrontal cortex30 and regulates brain cholinergic neurotransmission.31 This receptor is thus involved in rodents' learning and memory function.31,32 It has been indicated that, among 5-HT6 receptor polymorphisms,33 T267C is associated with Alzheimer disease.34 Whether this polymorphism also contributes to variances in prefrontal function requires investigation. Although this is a silent mutation, it has been suggested that this variant may affect translation through the secondary structure and stability of mRNA or that it may be in linkage disequilibrium with a functional polymorphism.35

The current study aims to explore the effects of the aforementioned genetic variances of D1, D3, 5-HT2A and 5-HT6 on WCST performance, which reflects prefrontal executive function, in a healthy population.

Methods

Participants

This study was approved by the institutional review board of China Medical University Hospital and carried out in accordance with the Declaration of Helsinki (www.wma.net /e/policy/b3.htm). The participants were 216 unrelated healthy volunteers (81 men and 135 women) with a mean age of 48.6 (standard deviation [SD] 9.4) years (range 20–65 y) and a mean education level of 10.9 (SD 3.7) years (range 0–20 y). All were Han Chinese living in Taiwan. The subjects in this study gave their consent to participate after procedures were explained to them. All subjects were free of any axis I or II psychiatric disorders, as determined by a research psychiatrist using the Structured Clinical Interview for DSM-IV.36 All participants were also in good physical health, as determined by physical examination, electrocardiogram and laboratory tests including liver, renal and thyroid function tests and urinalysis.

WCST assessments

An experienced psychologist (Y-LC) administered the WCST.9,10 In this test, subjects are required to sort stimulus cards on the basis of perceptual attributes (colour, form, number). The only feedback provided by the administrator is to indicate whether each response is correct or incorrect. The sorting rule is changed after 10 consecutive correct responses. Testing is discontinued when the subject has reached 128 trials.37 The a priori primary outcome measure was the percentage of perseverative errors because it is sensitive to a person's ability to fluently shift cognitive sets and is thought to best reflect the prefrontal cognitive function.8 The accessory outcome variable was the number of categories completed, as used by other investigators.34 To minimize multiple comparisons, we determined a priori not to analyze other WCST parameters.

Genotyping

Genomic DNA was extracted from the subjects' white blood cells. The 4 polymorphisms were genotyped according to the polymerase chain reaction-restriction fragment length polymorphism technique.

Forward and reverse primers and restriction enzymes for each polymorphism were as follows: 5′-ACT GAC CCC TAT TCC CTG CT-3′, 5′-AGC ACA GAC CAG CGT GTT C-3′, DdeI for A-48G polymorphisms in the promoter region of the dopamine D1 receptor gene;38 5′-GCT CTA TCT CCA ACT CTC ACA-3′, 5′-AAG TCT ACT CAC CTC CAG GTA-3′, MscΙ for the D3 Ser9Gly polymorphism;39,40 5′-TCT GCT ACA AGT TCT GGC TT-3′, 5′-CTG CAG CTT TTT CTC TAG GG-3′, MspI for 5-HT2A T102C;41,42 and 5′-AAC TTC TTC CTG GTG TCG CTC TTC-3′, 5′-ATG AGC AGG TAG CGG TCC AGG-3′, RsaI for T267C polymorphisms in the 5-HT6 receptor gene.37,43

DNA fragments were visualized with 2% agarose gel electrophoresis and staining with ethidium bromide. Duplicate genotyping was conducted for all 4 polymorphisms, with 100% concordance. All assays were performed blind to the subjects' cognitive measurements.

Data analyses

We used a 2-tailed Mann–Whitney U test for WCST performance comparisons between male and female subjects. Kruskal–Wallis tests were carried out with each genetic polymorphism as the independent variable and percentage of perseverative errors and number of categories as the dependent measures. These nonparametric statistical methods were used because the distributions of perseverative errors and categories numbers were skewed to the right (data not shown). We also compared the subjects' demographic characteristics among genotypes of each genetic polymorphism, using Kruskal–Wallis tests for continuous variables and χ2 tests for categorical variables. Statistical significance was defined as p < 0.05 or corrected for multiple comparisons as needed (p < 0.0125 = 0.05/4 [genetic polymorphisms]).

To control for the effects of other confounding factors, we used multiple linear regression in a single analysis to evaluate impacts of sex, age, sex × age interaction, education level and the 4 genetic polymorphisms simultaneously on WCST performance. Because all these comparisons were performed in a single multiple regression analysis, no correction for multiple comparisons was required. However, the distributions of the WCST data were skewed to the right and unsuitable for regression analyses. To convert the skewed distribution to a normal one, we measured each perseverative error value in its natural logarithmic scale before the regression analysis.44,45

Results

In all 216 subjects, the mean percentage of WCST perseverative errors was 20.1% (SD 13.1%) and the mean number of WCST categories completed was 4.18 (SD 3.08). Men and women had comparable mean perseverative errors at 18.7 (SD 12.0) and 20.9 (SD 13.8) (p = 0.46), respectively, and comparable mean numbers of categories completed at 4.4 (SD 3.2) and 4.1 (SD 3.0) (p = 0.55).

Allele frequencies of the genetic polymorphisms in our Han Chinese sample are similar to those in other Han Chinese populations but may be different from those in white populations (Table 1). The genotype distribution of each of the 4 genetic polymorphisms did not deviate significantly from the Hardy–Weinberg equilibrium: D1 A-48G (χ2 = 0.839, p = 0.657), D3 S er9G1y (χ2 = 1.873, p = 0.392), 5-HT2A T102C (χ2 = 0.76, p = 0.683) and 5-HT6 T267C (χ2 = 1.17, p = 0.558).

Table 1

graphic file with name 7TT1.jpg

WCST perseverative errors and genotypes

Table 2 shows differences in WCST perseverative errors among genotypes of each of the 4 genetic variances. D3 Ser9Gly, 5-HT2A T102C and 5-HT6 T267C, but not D1 A-48G, significantly influenced perseverative errors. If corrected for multiple comparisons of the 4 genetic polymorphisms, D3 Ser9Gly and 5-HT6 T267C remained significant in modulating the functional outcome measures (α = 0.05/4 = 0.013). Sex, age and education level did not significantly differ among genotypes of each genetic polymorphism (all p values > 0.05, data not shown).

Table 2

graphic file with name 7TT2.jpg

Because various genetic factors may simultaneously determine executive function, we then conducted multiple linear regression analysis to evaluate effects of the 4 genetic polymorphisms on WCST perseverative errors after controlling for sex, age, gender × age interaction and education level. Prior to multiple regression, each WCST value was transformed to its natural logarithm to obtain normal distributions (data not shown). As revealed in Table 3, D1 A-48G, D3 Ser9Gly, 5-HT2A T102C and 5-HT6 T267C polymorphisms significantly influence perseverative errors after adjustment for sex, age, sex × age interaction, education level and other genetic variants. Compared with subjects having the D1 A-48G A/A genotype, those with A/G had a 74% more perseverative errors (e0.5561 = 1.7438, 1.7438 — 1 = 0.7438), and those with G/G had a 101% more perseverative errors (e0.6968 = 1.9447, 2.0073 – 1 = 1.0073). Compared with subjects with the D3 Ser9Gly Ser/Ser genotype, those with Ser/Gly had 23% more perseverative errors (e0.2103 = 1.2340). However, the difference in perseverative errors between those with Gly/Gly and those with Ser/Ser did not achieve statistical significance. Compared with subjects having the 5-HT2A T102C T/T genotype, those with T/C committed 25% more perseverative errors (e0.2257 = 1.2532). The 2 homozygote groups, however, did not have significant differences in perseverative errors. Compared with subjects with the 5-HT6 T267C T/T genotype, those with T/C had 42% fewer perseverative errors (e–0.5468 = 0.5788, 1 – 0.5788 = 0.4212) and those with C/C had 32% fewer errors (e–0.3920 = 0.6757, 1 – 0.6757 = 0.3243). Because all these comparisons were performed in a single multiple regression analysis (Table 3), no correction for multiple comparisons was needed. There was a sex × age interaction effect on perseverative errors. Compared with men, perseverative errors made by women increased less rapidly with age. Education level did not significantly influence the cognitive measures.

Table 3

graphic file with name 7TT3.jpg

Genotypes and WCST categories completed

Regarding the number of categories completed, we found that only the D3 Ser9Gly polymorphism had significant influence. The mean number of categories completed for the subjects with the Ser/Ser genotype was 4.7 (SD 3.1); for those with Ser/Gly, it was 3.7 (SD 3.1); and for those with Gly/Gly, it was 3.5 (SD 2.9) (p = 0.029). However, if corrected for the 4 multiple comparisons (see the above section), the difference did not achieve statistical significance. Multiple linear regression analysis also did not reveal statistical significance for any genetic variance. These findings support the notion that the percentage of perseverative errors is the most sensitive of the WCST parameters in terms of reflecting prefrontal function.8

Discussion

The main finding is that D1 A-48G, D3 Ser9Gly, 5-HT2A T102C and 5-HT6 T267C variants can significantly influence executive function in healthy adults, supporting the hypothesis that D1, D3, 5-HT2A and 5-HT6 receptors are involved in prefrontal executive cognition. Certainly, chance false-positive findings might have happened. Although we included a total of 216 subjects, cell sizes for some genotypes that were used as the basis of between-genotype comparisons were small (n = 5 and n = 12 for the D1 A-48G and 5-HT6 T267C polymorphisms, respectively). Larger samples are needed to substantiate the results.

Interestingly, while subjects homozygous for the D3 Ser/Ser genotype performed better in terms of perseverative errors than those heterozygous for Ser/Gly, subjects homozygous for Gly/Gly tended to have intermediate performances (although this was nonsignificant). This phenomenon is not unique for functional studies of D3 Ser/Gly polymorphisms. For instance, people homozygous for Gly/Gly demonstrate intermediate levels of eye movement disturbances whether they are schizophrenia patients or healthy subjects.19 Ser/Gly heterozygotic subjects have lower 5-hydroxyindoleacetic acid levels in their cerebral spinal fluid than Ser/Ser and Gly/Gly homozygotic subjects.46 Excess homozygosity (both the wild type and the variant) can also be a feature of certain subgroups of schizophrenia patients, such as those who respond to neuroleptic treatment.47 The heterozygote of the 5-HT2A T102C polymorphism also displayed unusual functional consequences. Whereas subjects with the 5-HT2A T/T genotype had the fewest perseverative errors, those with T/C (rather than those with C/C) had the poorest performances (Table 2, Table 3). In accordance, heterozygous patients with T/C have the lowest N100 amplitude when compared with the other 2 Han Chinese genetic groups.27 Last, 5-HT6 T267C polymorphisms may have similar effects. The T/T genotype was associated with the highest perecentage of perseverative errors, and the C/C genotype tended to have intermediate performance (Table 2, Table 3). Likewise, schizophrenia patients with the 5-HT6 C/C genotype show intermediate treatment response to clozapine, compared with those with T/T or T/C.35 Such findings on “positive or negative heterosis (the highest or lowest phenotypic expression in heterozygotes)”48 have been reported in the neuroscience49 and other50,51 literature.

An advantage of this study is the apparent ethnic homogeneity of Han Chinese people. In general, the Han Chinese population is genetically homogeneous. However, given the large population and the wide distribution of the Han Chinese, we cannot exclude the potential population admixture effect on the study results. Of note, cognitive capacity, as measured by performance on neuropsychological tests, is related to many aspects of function in schizophrenia patients.52,53 Whether our findings could be extrapolated to other ethnic populations or to patients with psychiatric disorders remains unclear. In another study,54 which recruited antipsychotics-treated schizophrenia patients, D1 A-48G, but not D3 Ser9Gly or D4 C-521T, influenced WCST performance. In female patients, a relation was also found between D2-141C Ins/Del polymorphism and perseverative errors. Patients with the G/G genotype of the D1 receptor gene tended to obtain poorer WCST results,54 similar to our finding in healthy people. The findings for the D3 variances differ from ours. Because both first-and second-generation antipsychotics act on D3 receptors,17,39 the potential confounding influences from drugs need consideration. Differences in subject ethnicity may also contribute to the discrepancy.

The WCST perseverative error performance in this study is similar to that in another healthy Chinese population55 but inferior to that in a healthy white population.56 Further, the percentage of perseverative errors and the number of completed categories in the healthy population in the current study are similar to the results obtained in schizophrenia patients in studies performed in the United States and Europe.8,11 In conclusion, although our results are of interest, the definitive answers and the possible applications to other ethnic groups or mentally ill patients require future, larger studies. Besides, the question of whether polymorphisms of other serotonin or dopamine receptors or serotonin or norepinephrine transporters (the latter of which is responsible for dopamine reuptake in the prefrontal cortex) are also associated with WCST performance deserves more study. Finally, glutamate neurotransmission57–59 and other pathways2 are also crucial for high cortical function in the prefrontal areas. Therefore, possible effects of other genetic variances than dopamine-or serotonin-related ones on executive function or other neuroncognitions60 also require elucidation.

Acknowledgments

This study was supported by the National Science Council (Taiwan) NSC-94-2314-B-039-026, NSC-95-2314-B-006-119, NSC-95-2314-B-006-118-MY3; the National Health Research Institutes (Taiwan) NHRI-EX-96-9405PI, the National Research Program for Genomic Medicine (Taiwan) 94DOH004, the Committee on Chinese Medicine and Pharmacy (Taiwan) CCMP94-RD-041-1, the Department of Health (Taiwan), China Medical University Hospital (Taiwan) DMR-94-064, and National Cheng Kung University Project of Promoting Academic Excellence and Developing World Class Research Centers (Taiwan).

Footnotes

Contributors: Drs. Lane and Liu designed the study. Drs. Lane, Huang, Hsieh, Mr. Y-L Chang and Ms. L. Chang acquired the data, which Drs. Lane, Liu, Y-C Chang and W-H Chang analyzed. Dr. Lane wrote the article, and all authors revised it. All authors gave final approval for the article to be published.

Competing interests: None declared.

Correspondence to: Dr. Hsien-Yuan Lane, China Medical University Hospital (Taiwan), Department of Psychiatry, No. 2, Yuh-Der Road, Taichung, Taiwan 404; fax 886-4-2236-1230; hylane@gmail.com

References

  • 1.Thompson PM, Cannon TD, Narr KL, et al. Genetic influences on brain structure. Nat Neurosci 2001;4:1253-8. [DOI] [PubMed]
  • 2.Butcher LM, Kennedy JK, Plomin R. Generalist genes and cognitive neuroscience. Curr Opin Neurobiol 2006;16:145-51. [DOI] [PubMed]
  • 3.Passetti F, Dalley JW, Robbins TW. Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology (Berl) 2003;165:136-45. [DOI] [PubMed]
  • 4.Backman L, Ginovart N, Dixon RA, et al. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry 2000;157:635-7. [DOI] [PubMed]
  • 5.Rihet P, Possamai CA, Micallef-Roll J, et al. Dopamine and human information processing: a reaction-time analysis of the effect of levodopa in healthy subjects. Psychopharmacology (Berl) 2002;163:62-7. [DOI] [PubMed]
  • 6.Volkow ND, Gur RC, Wang GJ, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998;155:344-9. [DOI] [PubMed]
  • 7.Weinberger DR, Egan MF, Bertolino A, et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001;50:825-44. [DOI] [PubMed]
  • 8.Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001;98:6917-22. [DOI] [PMC free article] [PubMed]
  • 9.Hellman SG, Kern RS, Neilson LM, et al. Monetary reinforcement and Wisconsin Card Sorting performance in schizophrenia: why show me the money? Schizophr Res 1998;34:67-75. [DOI] [PubMed]
  • 10.Sergi MJ, Rassovsky Y, Widmark C, et al. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res 2007;90:316-24. [DOI] [PubMed]
  • 11.Barnett JH, Jones PB, Robbins TW, et al. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 2007;12:502-9. [DOI] [PubMed]
  • 12.Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995;376:572-5. [DOI] [PubMed]
  • 13.Di Cara B, Panayi F, Gobert A, et al. Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats. Int J Neuropsychopharmacol 2007;10:383-99. Epub 2006 Aug 22. [DOI] [PubMed]
  • 14.Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 2003;54:515-28. [DOI] [PubMed]
  • 15.Potkin SG, Basile VS, Jin Y, et al. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol Psychiatry 2003;8:109-13. [DOI] [PubMed]
  • 16.Glickstein SB, Hof PR, Schmauss C. Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits. J Neurosci 2002;22:5619-29. [DOI] [PMC free article] [PubMed]
  • 17.Schwartz JC, Diaz J, Pilon C, et al. Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions. Brain Res Brain Res Rev 2000;31:277-87. [DOI] [PubMed]
  • 18.Black KJ, Hershey T, Koller JM, et al. A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci U S A 2002;99:17113-8. [DOI] [PMC free article] [PubMed]
  • 19.Rybakowski JK, Borkowska A, Czerski PM, et al. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Mol Psychiatry 2001;6:718-24. [DOI] [PubMed]
  • 20.Nieman DH, Bour LJ, Linszen DH, et al. Neuropsychological and clinical correlates of antisaccade task performance in schizophrenia. Neurology 2000;54:866-71. [DOI] [PubMed]
  • 21.Park S. Association of an oculomotor delayed response task and the Wisconsin Card Sort Test in schizophrenic patients. Int J Psychophysiol 1997;27:147-51. [DOI] [PubMed]
  • 22.Moore T, Armstrong KM. Selective gating of visual signals by microstimulation of frontal cortex. Nature 2003;421:370-3. [DOI] [PubMed]
  • 23.Buhot MC, Martin S, Segu L. Role of serotonin in memory impairment. Ann Med 2000;32:210-21. [DOI] [PubMed]
  • 24.Umbricht D, Vollenweider FX, Schmid L, et al. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 2003;28:170-81. [DOI] [PubMed]
  • 25.Perlstein WM, Dixit NK, Carter CS, et al. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry 2003;53:25-38. [DOI] [PubMed]
  • 26.Arranz M, Collier D, Sodhi M, et al. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 1995; 346:281-2. [DOI] [PubMed]
  • 27.Yu YW, Tsai SJ, Yang KH, et al. Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine. Neuropsychobiology 2001;43:79-82. [DOI] [PubMed]
  • 28.Tzourio N, Massioui FE, Crivello F, et al. Functional anatomy of human auditory attention studied with PET. Neuroimage 1997; 5:63-77. [DOI] [PubMed]
  • 29.Polesskaya OO, Sokolov BP. Differential expression of the “C” and “T” alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002; 67: 812-22. [DOI] [PubMed]
  • 30.Matsumoto M, Togashi H, Mori K, et al. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex. Eur J Pharmacol 1999;383:39-48. [DOI] [PubMed]
  • 31.Branchek TA, Blackburn TP. 5-HT6 receptors as emerging targets for drug discovery. Annu Rev Pharmacol Toxicol 2000;40:319-34. [DOI] [PubMed]
  • 32.Meneses A. Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation. Behav Brain Res 2001;118:107-10. [DOI] [PubMed]
  • 33.Vogt IR, Shimron-Abarbanell D, Neidt H, et al. Investigation of the human serotonin 6 (5-HT6) receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 2000;96:217-21. [PubMed]
  • 34.Tsai SJ, Liu HC, Liu TY, et al. Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease. Neurosci Lett 1999; 276:138-9. [DOI] [PubMed]
  • 35.Yu YW, Tsai S., Lin CH, et al. Serotonin-6 receptor variant (C267T) and clinical response to clozapine. Neuroreport 1999;10:1231-3. [DOI] [PubMed]
  • 36.American Psychiatric Association. Structured Clinical Interview for DSM-IV. Washington: American Psychiatric Press; 1995.
  • 37.Heaton RK, Chelune GJ, Talley JL, et al. Wisconsin card sorting test manual: revised and expanded. Odessa (FL): Psychological Assessment Resources; 1993.
  • 38.Ni X, Trakalo JM, Mundo E, et al. Linkage disequilibrium between dopamine D1 receptor gene (DRD1) and bipolar disorder. Biol Psychiatry 2002;52:1144-50. [DOI] [PubMed]
  • 39.Lane HY, Hsu SK, Liu YC, et al. Dopamine D3 receptor Ser9Gly polymorphism and risperidone response: a rigorous pharmacogenetic study. J Clin Psychopharmacol 2005;25:6-11. [DOI] [PubMed]
  • 40.Segman R, Neeman T, Heresco-Levy U, et al. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 1999;4:247-53. [DOI] [PubMed]
  • 41.Chen CH, Lee YR, Wei FC, et al. Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese. Psychiatr Genet 1997;7:35-8. [DOI] [PubMed]
  • 42.Lane HY, Chang YC, Chiu CC, et al. Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene. Am J Psychiatry 2002;159:1593-5. [DOI] [PubMed]
  • 43.Masellis M, Basile VS, Meltzer HY, et al. Lack of association between the T→C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr Res 2001;47:49-58. [DOI] [PubMed]
  • 44.Bolton S, Bon C. Pharmaceutical statistics: practical and clinical applications. 4th ed. New York: Dekker; 1997. 290-8.
  • 45.Lane HY, Chang YC, Chang WH, et al. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. J Clin Psychiatry 1999;60:36-40. [DOI] [PubMed]
  • 46.Jonsson E, Sedvall G, Brene S, et al. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 1996;40:1032-43. [DOI] [PubMed]
  • 47.Mant R, Williams J, Asherson P, et al. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet 1994;54:21-6. [DOI] [PubMed]
  • 48.Melville R. Co-existence of positive and negative heterosis in a single plant organ. Nature 1952;169:1054-5. [DOI] [PubMed]
  • 49.Annett M. The theory of an agnosic right shift gene in schizophrenia and autism. Schizophr Res 1999;39:177-82. [DOI] [PubMed]
  • 50.Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283:1748-52. [DOI] [PubMed]
  • 51.Super M. Heterozygote disadvantage in cystic fibrosis. Lancet 1977; 2: 1288. [DOI] [PubMed]
  • 52.Carpenter WT Jr. Targeting schizophrenia research to patient outcomes. Am J Psychiatry 2006;163:353-5. [DOI] [PubMed]
  • 53.Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321-30. [DOI] [PubMed]
  • 54.Rybakowski JK, Borkowska A, Czerski PM, et al. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J Neural Transm 2005;112:1575-82. [DOI] [PubMed]
  • 55.Tsai SJ, Yu YW, Chen TJ, et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003;338:123-6. [DOI] [PubMed]
  • 56.Merriam EP, Thase ME, Haas GL, et al. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psychiatry 1999;156:780-2. [DOI] [PubMed]
  • 57.Deutsch SI, Schwartz BL, Rosse RB, et al. Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia. Clin Neuropharmacol 2003; 26: 199-206. [DOI] [PubMed]
  • 58.Goldberg TE, Straub RE, Callicott JH, et al. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006;31:2022-32. [DOI] [PubMed]
  • 59.Holden C. Psychiatric drugs. Excited by glutamate. Science 2003;300:1866-8. [DOI] [PubMed]
  • 60.Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 2004;56:301-7. [DOI] [PubMed]

Articles from Journal of Psychiatry & Neuroscience : JPN are provided here courtesy of Canadian Science Publishing

RESOURCES